Pharmacological and nonpharmacological strategies to treat and manage comorbid schizophrenia and addiction concern psychiatrists who are learning strategies to help improve functional outcomes.
Can antipsychotics impact substance use or vocational outcomes in patients with schizophrenia? Dr Douglas L. Noordsy, Associate Professor of Psychiatry and Director of Psychosis Services at Geisel School of Medicine at Dartmouth, New Hampshire, will be answering that question and more during his presentation with the same title at the 2012 US Psychiatric and Mental Health Congress in San Diego.
Here, Dr. Noordsy shares some highlights of the presentation and sheds some light on the pharmacological and nonpharmacological strategies to treat and manage comorbid schizophrenia and addiction as well as strategies to help improve functional outcomes.
Comorbid Schizophrenia and Substance Use